Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ATAI LIFE SCIENCES N.V.

(ATAI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Asian ADRs Move Lower in Monday Trading

06/21/2021 | 10:40am EST


ę MT Newswires 2021
All news about ATAI LIFE SCIENCES N.V.
11/22HC Wainwright Adjusts Atai Life Sciences to $50 From $40, Reiterates Buy Rating
MT
11/17Berenberg Bank Adjusts Atai Life Sciences' Price Target to $38 From $35, Maintains Buy ..
MT
11/16RBC Trims Price Target on Atai Life Sciences to $17 From $19, Maintains Sector Perform ..
MT
11/15ATAI LIFE SCIENCES N.V. Management's Discussion and Analysis of Financial Condition an..
AQ
11/15European ADRs Move Slightly Higher in Monday Trading
MT
11/15ATAI Life Sciences' Q3 Loss Narrows
MT
11/15ATAI LIFE SCIENCES N : Reports Third Quarter 2021 Financial Results and Corporate Update -..
PU
11/15Atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
AQ
11/11Roth Capital Starts Atai Life Sciences at Buy With $32 Price Target
MT
11/05Atai Life Sciences to Participate in Upcoming November Investor Conferences
AQ
More news
Analyst Recommendations on ATAI LIFE SCIENCES N.V.
More recommendations
Financials (USD)
Sales 2021 18,4 M - -
Net income 2021 -118 M - -
Net cash 2021 407 M - -
P/E ratio 2021 -13,5x
Yield 2021 -
Capitalization 1 794 M 1 794 M -
EV / Sales 2021 75,3x
EV / Sales 2022 22 224x
Nbr of Employees 35
Free-Float 90,8%
Chart ATAI LIFE SCIENCES N.V.
Duration : Period :
Atai Life Sciences N.V. Technical Analysis Chart | ATAI | NL0015000DX5 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 11,19 $
Average target price 30,33 $
Spread / Average Target 171%
EPS Revisions
Managers and Directors
Florian Brand Chief Executive Officer
Gregory L. Weaver Chief Financial Officer
Srinivas G. Rao Chief Scientific Officer
Rolando GutÝerrez-Esteinou Chief Medical Officer
Alexis Marc Joel Louis de Rosnay Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ATAI LIFE SCIENCES N.V.0.00%1 794
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431